Literature DB >> 10490948

Cutting edge: mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12.

E L Faquim-Mauro1, R L Coffman, I A Abrahamsohn, M S Macedo.   

Abstract

IL-4-dependent and -independent IgG1 Abs differ in their ability to induce mast cell degranulation as measured by passive cutaneous anaphylaxis (PCA). Mice immunized with OVA or PIII (fraction of Ascaris suum) produced high titers of IgG1 as shown by ELISA and PCA. In contrast, another A. suum fraction, PI, elicited IgG1 Abs with no PCA activity. IgG1 with anaphylactic activity required IL-4, as IgG1 responses to OVA and PIII in IL-4-/- mice gave no PCA. PI-specific IgG1 was IL-4-independent, because no difference was found between the responses of IL-4-/- and IL-4+/+ mice. Significant PCA reactions were elicited, however, with PI-specific IgG1 from IL-12-/- or anti-IFN-gamma Ab-treated mice, although less Ab was measured by ELISA. These results indicate that one type of IgG1 has anaphylactic activity and its synthesis is IL-4-dependent, being inhibited by IL-12 or IFN-gamma; the other lacks this activity and its synthesis is stimulated by IL-12 or IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490948

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  T-cell expression cloning of Porphyromonas gingivalis genes coding for T helper-biased immune responses during infection.

Authors:  Reginaldo B Gonçalves; Onir Leshem; Karen Bernards; John R Webb; Philip P Stashenko; Antonio Campos-Neto
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer.

Authors:  Christine Mall; Gail D Sckisel; David A Proia; Annie Mirsoian; Steven K Grossenbacher; Chien-Chun Steven Pai; Mingyi Chen; Arta M Monjazeb; Karen Kelly; Bruce R Blazar; William J Murphy
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

3.  Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein.

Authors:  R Weiss; W W Leitner; S Scheiblhofer; D Chen; A Bernhaupt; S Mostböck; J Thalhamer; J A Lyon
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4.

Authors:  E L Munson; B K Du Chateau; D A Jobe; S D Lovrich; S M Callister; R F Schell
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Identification of Leishmania infantum chagasi proteins in urine of patients with visceral leishmaniasis: a promising antigen discovery approach of vaccine candidates.

Authors:  S S Kashino; C Abeijon; L Qin; K A Kanunfre; F S Kubrusly; F O Silva; D L Costa; D Campos; C H N Costa; I Raw; A Campos-Neto
Journal:  Parasite Immunol       Date:  2012-07       Impact factor: 2.280

6.  Development of a BALB/c mouse model for food allergy: comparison of allergy-related responses to peanut agglutinin, β-lactoglobulin and potato acid phosphatase.

Authors:  Chen Chen; Lu Lianhua; Sun Nana; Li Yongning; Jia Xudong
Journal:  Toxicol Res (Camb)       Date:  2017-01-16       Impact factor: 3.524

7.  Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.

Authors:  Javier Cote-Sierra; Amin Bredan; Carmen M Toldos; Benoit Stijlemans; Lea Brys; Pierre Cornelis; Manuel Segovia; Patrick de Baetselier; Hilde Revets
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

8.  Th1 biased response to a novel Porphyromonas gingivalis protein aggravates bone resorption caused by this oral pathogen.

Authors:  Onir Leshem; Suely S Kashino; Reginaldo B Gonçalves; Noriyuki Suzuki; Masao Onodera; Akira Fujimura; Hajime Sasaki; Philip Stashenko; Antonio Campos-Neto
Journal:  Microbes Infect       Date:  2008-03-25       Impact factor: 2.700

9.  CpG-induced Th1-type response in the downmodulation of early development of allergy and inhibition of B7 expression on T cells of newborn mice.

Authors:  Cyro A de Brito; Ana E Fusaro; Jefferson R Victor; Paula O Rigato; Adriana L Goldoni; Bruno P Muniz; Alberto J S Duarte; Maria N Sato
Journal:  J Clin Immunol       Date:  2010-01-19       Impact factor: 8.317

10.  CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis.

Authors:  J Reynolds; F W Tam; A Chandraker; J Smith; A M Karkar; J Cross; R Peach; M H Sayegh; C D Pusey
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.